Company News, All Bradley Cocks 18/4/24 Company News, All Bradley Cocks 18/4/24

Jumar Bioincubator opening, Melbourne | Home to Arovella's new office

Read More

Company News, All Michelle Long 9/4/24 Company News, All Michelle Long 9/4/24

Arovella presents ALA-101 data at AACR

Read More

All, Company News Michelle Long 3/4/24 All, Company News Michelle Long 3/4/24

Arovella expands Scientific Advisory Board with the appointment of Professor Gianpietro Dotti

Read More

Company News, All Bradley Cocks 27/3/24 Company News, All Bradley Cocks 27/3/24

Arovella to present at AACR Annual Meeting

Read More

Company News, All Bradley Cocks 26/3/24 Company News, All Bradley Cocks 26/3/24

Arovella funded to Phase 1 data: completes $12.5m placement

Read More

Presentations & Webinars, All Bradley Cocks 25/3/24 Presentations & Webinars, All Bradley Cocks 25/3/24

ASX Gems Conference 2024

Read More

Presentations & Webinars, All Bradley Cocks 20/3/24 Presentations & Webinars, All Bradley Cocks 20/3/24

NWR Virtual Healthcare Conference

Read More

Presentations & Webinars, All Michelle Long 14/3/24 Presentations & Webinars, All Michelle Long 14/3/24

Spark Plus Singapore Healthcare Day Presentation

Read More

Media, All Michelle Long 20/2/24 Media, All Michelle Long 20/2/24

CEO Michael Baker’s interview with JustStocks

Read More

Media, All Michelle Long 30/1/24 Media, All Michelle Long 30/1/24

Arovella licenses novel CAR-iNKT cell armouring technology: Media coverage

Read More

Company News, Presentations & Webinars, All Michelle Long 30/1/24 Company News, Presentations & Webinars, All Michelle Long 30/1/24

Arovella enhances solid tumour pipeline by licensing novel CAR-iNKT cell armouring technology

Read More

Company News, All Michelle Long 2/1/24 Company News, All Michelle Long 2/1/24

Arovella completes key manufacturing step to progress ALA‐101 to clinic

Read More

Presentations & Webinars, All Michelle Long 11/12/23 Presentations & Webinars, All Michelle Long 11/12/23

CAR-iNKT cell platform data presented at ASH 2023

Read More

Newsletter, All Michelle Long 4/12/23 Newsletter, All Michelle Long 4/12/23

Arovella Newsletter December 2023

Read More

Presentations & Webinars, All Michelle Long 21/11/23 Presentations & Webinars, All Michelle Long 21/11/23

Monsoon Twilight Investor Briefing Presentation

Read More

Company News, All Michelle Long 20/11/23 Company News, All Michelle Long 20/11/23

Arovella receives R&D tax credit of $1.94m

Read More

Company News, All Michelle Long 10/11/23 Company News, All Michelle Long 10/11/23

AGM Chairman's Address and CEO & MD Presentation

Read More

Media, All Michelle Long 9/11/23 Media, All Michelle Long 9/11/23

Arovella Therapeutics partners with Cell Therapies to develop its ALA-101 manufacturing process for cancer clinical trials

Read More

Presentations & Webinars, All Michelle Long 3/11/23 Presentations & Webinars, All Michelle Long 3/11/23

Emerging ASX gems conference presentation

Read More

Presentations & Webinars, All Michelle Long 30/10/23 Presentations & Webinars, All Michelle Long 30/10/23

AusBioInvest Presentation

Read More